Dual Diagnosis Self-Help Referral
|Study Design:||Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Dual Diagnosis Self-Help Group Referral: Outcomes and Services Use|
- Psychiatric Functioning at 6 Months [ Time Frame: 6 months ]Addiction Severity Index psychiatric composite ranges from 0 to 1, with 1 indicating more severe problems.
- Mental Health Services Use and Costs at 6 Months, 1 Year, and 2 Years [ Time Frame: 6 months, 1 year, 2 years ]
|Study Start Date:||April 2006|
|Study Completion Date:||September 2010|
|Primary Completion Date:||September 2010 (Final data collection date for primary outcome measure)|
Experimental: Arm 1
Intensive referral to dual-focused self-help groups
Behavioral: Intensive referral to dual-focused self-help
4 group sessions to introduce patients to dual focused groups
No Intervention: Arm 2
Dual diagnosis (psychiatric and substance use) patients' (DDPs) participation in 12-step mutual-help groups is linked to lower relapse and treatment utilization rates. However, under usual referral, many DDPs do not attend, or sustain attendance of, substance-focused groups (SFG). DDPs may benefit from dual-focused groups (DFGs).
(1) Implement and validate procedures to help counselors make effective referrals to DFGs. DDPs were assigned to a standard- or intensive-referral to DFG condition to determine the extent to which intensive referral, compared to standard referral, increased patients' mutual-help group participation. (2) Determine whether DDPs who received intensive referral had better substance use and psychiatric outcomes.
DDPs entering VA outpatient mental health treatment received either standard (N=145) or intensive (N=142) referral. Standard referral consisted essentially of the counselor recommending DFG participation. The keys to intensive referral were a DFG orientation and the counselor facilitating direct contact between the patient and a DFG member, and following up on recommendations for mutual help. Patients were followed at six months (80%), one year (81%) and two years (80%) to determine whether intensive referral resulted in more DFG and SFG participation, and better substance use and psychiatric outcomes.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00286728
|United States, California|
|VA Palo Alto Health Care System, Palo Alto, CA|
|Palo Alto, California, United States, 94304-1290|
|Principal Investigator:||Christine Timko, PhD||VA Palo Alto Health Care System, Palo Alto, CA|